Product Code: ETC104567 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Indonesia Electrophoresisãâà market currently, in 2023, has witnessed an HHI of 6822, Which has increased substantially as compared to the HHI of 5475 in 2017. The market is moving towards Highly concentrated. Herfindahl index measures the competitiveness of exporting countries. The range lies from 0 to 10000, where a lower index number represents a larger number of players or exporting countries in the market while a large index number means fewer numbers of players or countries exporting in the market.
Indonesia electrophoresis market is expected to witness significant growth over the forecast period owing to growing demand from various end-use industries such as biotechnology, medical diagnostics, and research & development. Furthermore, increasing prevalence of chronic diseases in Indonesia and technological advancement are also driving the market for electrophoresis in Indonesia. Increasing governmental support towards research & development activities is anticipated to boost the demand for electrophoresis products in the country.
With increased government funding across a variety of sectors, there has been an increase in sales of eletrophoresis equipment and supplies across Indonesia over recent years. This has resulted in increased usage within healthcare facilities and academic institutions throughout the nation. Additionally, with rising awareness about reliable diagnostic techniques within both private and public segments, there has been greater adoption of advanced technologies such as capillary electrophoresis (CE), which will further fuel growth prospects during the forecast period (2025-2031).
The key drivers influencing Indonesia electrophorese market include rising investments by multinational corporations for manufacturing operations within the region; introduction of innovative tools aimed at accelerating diagnosis processes; surging number of patients suffering from cardiovascular diseases resulting from lifestyle changes; implementation of stringent regulations related to quality control procedures; growing emphasis on personalized medicine approaches among clinicians; advancements made in mobile computing platforms enabling real-time analysis capabilities; increasing application scope due to high sensitivity nature off CE systems etc.
The COVID-19 pandemic has had a major impact on the global electrophoresis market, including in Indonesia. The outbreak has led to a decline in demand for electrophoresis products, as well as disruptions across the supply chain due to logistical issues and reduced manufacturing capacity. Moreover, restrictions imposed by governments have impacted the ability of businesses to operate at full capacity.
However, while there are challenges presented by the outbreak which may cause difficulties for companies operating within this sector of healthcare, it is also an opportunity for businesses to explore new strategies and technologies that can help them stay competitive in the future. This includes exploring opportunities related to digitalization and enhanced automation processes as well as leveraging big data analytics and artificial intelligence capabilities.
In terms of key players within Indonesia electrophoresis market, some of these include Beckman Coulter Life Sciences (now part of Danaher Corporation), Bio Rad Laboratories Inc., Thermo Fisher Scientific Inc., GE Healthcare Life Sciences Division (formerly Amersham Biosciences) and Merck Millipore. These companies offer a range of products including gel documentation systems, imaging systems, software solutions and consumables such as buffers and reagents used for various types of protein or nucleic acid separation techniques such as SDS-PAGE or capillary electrophoresis.